Jiawei Zhao

机构：China Pharmaceutical University, Inner Mongolia University of Technology

发表论文 22 篇 · 总被引 438 次 · h-index 8

代表论文

• Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis (2024 · Cell Host & Microbe · 被引 178)
• Eubacterium coprostanoligenes alleviates chemotherapy-induced intestinal mucositis by enhancing intestinal mucus barrier (2023 · Acta Pharmaceutica Sinica B · 被引 66)
• ALDOA maintains NLRP3 inflammasome activation by controlling AMPK activation (2021 · Autophagy · 被引 65)
• Oroxylin A maintains the colonic mucus barrier to reduce disease susceptibility by reconstituting a dietary fiber-deprived gut microbiota (2021 · Cancer Letters · 被引 42)
• The flavonoid GL‐V9 alleviates liver fibrosis by triggering senescence by regulating the transcription factor GATA4 in activated hepatic stellate cells (2022 · British Journal of Pharmacology · 被引 23)
• Giant dielectric behavior from multiple effects in (Na+Ta) co-doped TiO2 ceramics (2025 · Ceramics International · 被引 18)